These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19028836)

  • 1. Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine.
    Pallanti S; Bernardi S; Allen A; Chaplin W; Watner D; DeCaria CM; Hollander E
    J Psychopharmacol; 2010 Jun; 24(6):847-53. PubMed ID: 19028836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine.
    Siever LJ; Uhde TW
    Biol Psychiatry; 1984 Feb; 19(2):131-56. PubMed ID: 6324896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration.
    Baumann MH; Milchanowski AB; Rothman RB
    Neuroscience; 2004; 125(3):683-90. PubMed ID: 15099682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan.
    Pallanti S; Bernardi S; Allen A; Hollander E
    J Psychopharmacol; 2010 Dec; 24(12):1802-9. PubMed ID: 19825906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function.
    Cameron OG; Abelson JL; Young EA
    Biol Psychiatry; 2004 Dec; 56(11):875-83. PubMed ID: 15576065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone secretion in response to the new centrally acting antihypertensive agent moxonidine in normal human subjects: comparison to clonidine and GHRH.
    Bamberger CM; Mönig H; Mill G; Gödde E; Schulte HM
    Exp Clin Endocrinol Diabetes; 1995; 103(3):205-8. PubMed ID: 7584524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma growth hormone responses to microinfusion of noradrenergic agents into or electrical stimulation of the hypothalamus and amygdala in baboons.
    McWilliam JR; Meldrum BS
    Horm Metab Res; 1985 Sep; 17(9):443-7. PubMed ID: 2995219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four hour growth hormone secretion in patients with panic disorder.
    Abelson JL; Curtis GC; Uhde TW
    Psychoneuroendocrinology; 2005 Jan; 30(1):72-9. PubMed ID: 15358444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I. Growth hormone response to clonidine stimulation.
    Brambilla F; Perna G; Bellodi L; Arancio C; Bertani A; Perini G; Carraro C; Gava F
    Psychiatry Res; 1997 Mar; 69(2-3):155-62. PubMed ID: 9109183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M; Wilkins A; Werstiuk ES; Steiner M
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy.
    Giustina A; Buffoli MG; Bussi AR; Doga M; Girelli A; Pizzocolo G; Pozzi A; Wehrenberg WB
    Horm Metab Res; 1992 May; 24(5):240-3. PubMed ID: 1398465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted growth hormone response to clonidine in post-traumatic stress disorder.
    Morris P; Hopwood M; Maguire K; Norman T; Schweitzer I
    Psychoneuroendocrinology; 2004 Feb; 29(2):269-78. PubMed ID: 14604605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
    De Gennaro Colonna V; Zoli M; Settembrini BP; Ciceri S; De Marco A; Cella SG; Agnati LF; Muller EE
    J Pharmacol Exp Ther; 1996 Feb; 276(2):795-800. PubMed ID: 8632352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological performance and noradrenaline function in chronic fatigue syndrome under conditions of high arousal.
    Morriss RK; Robson MJ; Deakin JF
    Psychopharmacology (Berl); 2002 Sep; 163(2):166-73. PubMed ID: 12202963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between morphine, an opioid agonist, and clonidine, an alpha-adrenergic agonist, on the regulation of anterior pituitary hormone secretion in normal male subjects.
    Pende A; Musso NR; Montaldi ML; Arzese M; Vergassola C; Devilla L
    Biomed Pharmacother; 1987; 41(5):243-7. PubMed ID: 3663877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults.
    Kimber J; Sivenandan M; Watson L; Mathias CJ
    Growth Horm IGF Res; 2001 Apr; 11(2):128-35. PubMed ID: 11472079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of alpha-2 adrenergic agonists on memory and cognitive flexibility.
    Choi Y; Novak JC; Hillier A; Votolato NA; Beversdorf DQ
    Cogn Behav Neurol; 2006 Dec; 19(4):204-7. PubMed ID: 17159617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects.
    Gerra G; Zaimovic A; Moi G; Bussandri M; Delsignore R; Caccavari R; Brambilla F
    Addict Biol; 2003 Mar; 8(1):23-32. PubMed ID: 12745412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone response to clonidine predicts aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Eryavec G; Van Reekum R; Khan LR
    Psychoneuroendocrinology; 2004 Oct; 29(9):1192-7. PubMed ID: 15219643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.